Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy
NCT05112627
·
clinicaltrials.gov ↗
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Renal Cell Carcinoma
Stage IV Renal Cell Cancer AJCC v8
Interventions
PROCEDURE:
Biospecimen Collection
Sponsor
Mayo Clinic